| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.1 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.089 | 0.1 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | 0.063 | 0.1 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.1 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.1 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | -0.08 | 0.1 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |